Pharma Finance and Investment News
Sichon Shutterstock
Bruker announces acquisition of RECIPE
Bruker Corporation has announced a majority investment in RECIPE Chemicals + Instruments, based in Munich, Germany.
28 Apr 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Garun Studios Shutterstock
Concept Life Sciences gains investments to strengthen drug discovery capabilities
Concept Life Sciences has announced key strategic appointments and advancements to further strengthen its services for the global pharmaceutical and biotechnology sectors.
16 Apr 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Thapana_Studio Shutterstock
Bormioli Pharma boosts revenues and earnings
Gerresheimer recorded a jump in revenues and earnings due to the first-time consolidation of Bormioli Pharma, which was acquired in 2024.
11 Apr 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Aelius Biotech
Scientists behind laboratory gut model raise funds for further expansion
Aelius Biotech, whose laboratory gut model is used to trial new drugs without the need for animal testing has raised £750,000 from the North East Venture Fund, supported by the European Regional Development Fund and managed by Mercia Ventures.
8 Apr 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Linda Bestwick Shutterstock
Academy of Medical Sciences funds emerging scientific leaders
In its largest-ever funding initiative for early-career researchers, the Academy of Medical Sciences is investing £7.6 million to tackle urgent health challenges from Alzheimer’s disease, cancer and obesity to addiction and climate change impacts.
7 Apr 2025
Pharma Manufacturing News + Pharma Finance and Investment News
B4B Payments
B4B Payments strengthens its presence in the pharma sector
As a specialist in scalable, secure corporate payment solutions, B4B Payments continues to enhance its support for the pharmaceutical sector, offering innovative, compliance-friendly solutions to streamline operations and improve financial processes.
27 Mar 2025
Pharma Manufacturing News + Pharma Finance and Investment News
VDB Photos Shutterstock
Likarda receives grant to deliver antibody-secreting cell therapy
Likarda announced a new grant from the Gates Foundation that supports the company’s proprietary Core-Shell Spherification (CSS) system to extend the therapeutic potential of a cost-effective cell-based therapy for infectious diseases.
27 Mar 2025
Pharma Manufacturing News + Pharma Finance and Investment News
TRIMTECH Therapeutics
TRIMTECH Therapeutics raises $31M seed funding
TRIMTECH Therapeutics, a biotech company harnessing targeted protein degradation (TPD) for the treatment of neurodegenerative diseases, today announced the closing of its $31 million (£25 million) seed funding round.
10 Mar 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Marc Schaad, Kistler CEO
Kistler CEO shares expectations for 2025
Kistler CEO, Marc Schaad, discussions their expectations for the company for 2025.
3 Mar 2025
Pharma Manufacturing News + Pharma Finance and Investment News
Tjoapack
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Aptamer
Aptamer announces new data at ASGCT
Aptamer Group presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting in New Orleans, LA (13-17 May 2025).
16 May 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
A9 STUDIO Shutterstock
Fette Compacting and CMIC enter into strategic partnership
Fette Compacting and CMIC CMO USA, a Contract Development and Manufacturing Organisation (CDMO), are entering into a strategic cooperation.
16 May 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Andrey Suslov Shutterstock
Honeywell AI-assisted recall software helps reduce recall impact
Honeywell has introduced TrackWise Recall Management, a cloud-based artificial intelligence (AI)-assisted platform that redefines how life sciences manufacturers proactively manage product recalls in order to improve patient safety.
16 May 2025
Thermo Fisher Scientific
Thermo Fisher Scientific introduces automated plasmid DNA purification kit
Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Pro HT NoSpin Plasmid MiniPrep Kit to address the critical need for rapid and automated plasmid DNA isolation, enabling scientists to conduct small-scale experiments quickly.
15 May 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Aenova
Aenova launches program to accelerate pharmaceutical development
Aenova, a contract development and manufacturing organisation (CDMO) in the global pharmaceutical supply chain, announces the launch of its Aenovation program.
15 May 2025
Pharma Manufacturing News + Latest Pharmaceutical Manufacturing News
Thapana_Studio Shutterstock
N4 Pharma announces positive results from first in vivo study
N4 Pharma has announced positive results from its first in vivo study evaluating the use of its Nuvec proof-of-concept programme.
14 May 2025
Pharma Manufacturing News + New Drug Development & Regulatory News
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Tjoapack
Tjoapack launches innovative customer dashboard to drive pharma supply chain collaboration
Tjoapack, a global contract packaging organisation, has announced the launch of its Customer Collaboration Dashboard, an innovative digital platform designed to streamline collaboration between Tjoapack and its clients.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00